Indefinite Delivery Contract SPE2D220D0091

This Indefinite Delivery Contract (IDC) award SPE2D220D0091 was made by the Defense Logistics Agency (DLA) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a ceiling value of $9,744,437.50 and a period of performance from April 29, 2020 through April 28, 2025. It is a national requirements contract to supply pramipexole dihydrochloride tablets in various dosages to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. The original solicitation was an unrestricted, fully competitive acquisition under FAR Part 12 for commercial items, with the goal of establishing a single-source supplier. The contract includes a one-year base period and four one-year option periods. Golden State Medical Supply, Inc. has consistently provided an extensive array of pharmaceutical products to government healthcare systems through its federal contract awards.

The parent company of the prime contractor, Gsms Inc., is also registered to receive federal contract awards, though the specific nature of its federal contracting activities is not detailed in the provided information. Without access to comprehensive federal procurement data, it is not possible to fully describe any Indefinite Delivery Vehicles (IDVs) held by Gsms Inc. or the types of goods and services it has supplied through past federal contract awards. The summarized information focuses on the prime contractor, Golden State Medical Supply, Inc., and the key details of the IDC award SPE2D220D0091 based on the provided materials.